The company said that the Xcelerant hydro delivery system is designed to aid navigation of the device through tight and tortuous arteries by reducing friction with the artery wall. The system was shown to generate 68 times less friction than the previous delivery system, which does not have the hydrophilic coating.
Katie Szyman, vice president and general manager of Medtronic’s endovascular innovations business, said: “Experience remains the foundation of our innovations in endovascular therapy, and the Xcelerant hydro delivery system represents our latest innovative contribution to this exciting field. Combined with the AneuRx AAAdvantage Stent Graft, Medtronic now offers US endovascular physicians an even stronger option for their endovascular repair procedures.”